Trial intelligence / Profile preview

Significance of Deviation in Time From 12-hour Serum-clozapine Monitoring

NCT02625103Phase 4Completed

Start
Sep 2015
Primary completion
Dec 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of clozapine in schizophrenia. Started Sep 2015; status: completed.

02

Drugs

clozapine
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT02625103.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02625103.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call